Exact Sciences Corp (EXAS)
65.96
-1.98
(-2.91%)
USD |
NASDAQ |
Sep 27, 16:00
65.99
+0.03
(+0.05%)
Pre-Market: 20:00
Exact Sciences Research and Development Expense (Annual): 425.88M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 425.88M |
| December 31, 2022 | 393.42M |
| December 31, 2021 | 385.65M |
| December 31, 2020 | 554.05M |
| December 31, 2019 | 139.69M |
| December 31, 2018 | 67.28M |
| December 31, 2017 | 42.10M |
| December 31, 2016 | 33.47M |
| December 31, 2015 | 33.91M |
| December 31, 2014 | 28.67M |
| December 31, 2013 | 27.68M |
| December 31, 2012 | 42.13M |
| December 31, 2011 | 21.97M |
| Date | Value |
|---|---|
| December 31, 2010 | 9.023M |
| December 31, 2009 | 4.213M |
| December 31, 2008 | 2.034M |
| December 31, 2007 | 4.887M |
| December 31, 2006 | 6.735M |
| December 31, 2005 | 7.843M |
| December 31, 2004 | 10.90M |
| December 31, 2003 | 17.08M |
| December 31, 2002 | 19.99M |
| December 31, 2001 | 13.34M |
| December 31, 2000 | 5.332M |
| December 31, 1999 | 3.689M |
| December 31, 1998 | 2.849M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
139.69M
Minimum
2019
554.05M
Maximum
2020
379.74M
Average
393.42M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Quest Diagnostics Inc | -- |
| Illumina Inc | 1.354B |
| Guardant Health Inc | 367.19M |
| Natera Inc | 320.68M |
| Castle Biosciences Inc | 53.62M |